Waters introduces SARS-CoV-2 LC-MS Kit to advance clinical research of infectious diseases
Waters Corporation has introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters SARSCoV- 2 LC-MS Kit (RUO) uses an orthogonal analytical method that directly detects and quantifies SARS-CoV-2 Nucleocapsid (NCAP) peptides that initial studies have shown to yield highly accurate, quantitative results.